Form 4/A for RGS REGIS CORP
Accepted 2024-11-19 00:00:00 ET · period of report 2024-11-05 · accession 0001415889-24-027260 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-11-19 | 2024-11-05 | RGS | Doctor Matthew | Pres, CEO, Dir | F - Tax | $23.37 | -547 | 3,084 | -15% | -$12.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-05 | F | D | 547 | $23.37 | 3,084 | D | — | — | (F1) The reporting person's Form 4 filed on November 7, 2024 inadvertently understated the shares withheld by 208 shares. (F2) Previous number of shares beneficially owned, 72,662, adjusted for 1-for-20 reverse stock split, to 3,631. This also corrects the share amount disposed for taxes on February 8, 2024, that was adjusted for the reverse split but subtracted from the unadjusted. |